Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.

Abstract: A composition comprising at least: a single extract obtained from a mixture of at least two plants selected from Chrysanthellum indicum, Cynara scolymus, Vaccinium myrtillus, Piper and Olea europaea. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.

Abstract: A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to <5% or of at least 5% of XAP units, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase.

Abstract: A composition comprising at least a mixture of molecules obtained at least from: Chrysanthellum indicum, Cynara scolymus, and Vaccinium myrtillus and wherein the mixture of molecules also comprises piperine. The composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.

Abstract: This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of Chrysanthellum indicum, an extract of Cynara scolymus, an extract of Vaccinium myrtillus, an extract of Olea europaea, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.

Abstract: The invention relates to a method of fabricating a thermal barrier comprising a ceramic coating layer covering at least a portion of the structure of a substrate, wherein the ceramic coating layer is deposited on the substrate solely by a cathodic electrodeposition process between at least one cathode (26) and at least one anode (28), the substrate being formed of an electron-conducting material and constituting the cathode. In characteristic manner, the electrolyte (24) comprises at least one salt from the group comprising the salts of lanthanides, of yttrium, of zirconium, and of hafnium, such that the coating layer applied by the electrodeposition process includes at least one oxide from the group comprising the oxides of lanthanides, of yttrium, of zirconium, and of hafnium, and it also includes a step of heat treating the ceramic coating layer at a temperature lying in the range 400° C. to 2000° C. for a duration of at least 10 min.

Abstract: The invention relates to a part comprising a substrate made of an electron-conducting material and a coating over at least a portion of the surface of the substrate, the coating comprising a ceramic coating layer. In characteristic manner, said coating layer is based on cerium oxides and said coating layer presents oxygen vacancies at a concentration greater than or equal to 1×1017/cm3. The invention is applicable to parts for high temperature applications, in particular in the field of aviation.

Abstract: The invention relates to a part comprising a substrate made of an electron-conducting material and a coating over at least a portion of the surface of the substrate, the coating comprising a ceramic coating layer. In characteristic manner, said coating layer is based on cerium oxides and said coating layer presents oxygen vacancies at a concentration greater than or equal to 1×1017/cm3. The invention is applicable to parts for high temperature applications, in particular in the field of aviation.

Abstract: The invention relates to a method of fabricating a thermal barrier comprising a ceramic coating layer covering at least a portion of the structure of a substrate, wherein the ceramic coating layer is deposited on the substrate solely by a cathodic electrodeposition process between at least one cathode (26) and at least one anode (28), the substrate being formed of an electron-conducting material and constituting the cathode. In characteristic manner, the electrolyte (24) comprises at least one salt from the group comprising the salts of lanthanides, of yttrium, of zirconium, and of hafnium, such that the coating layer applied by the electrodeposition process includes at least one oxide from the group comprising the oxides of lanthanides, of yttrium, of zirconium, and of hafnium, and it also includes a step of heat treating the ceramic coating layer at a temperature lying in the range 400° C. to 2000° C. for a duration of at least 10 min.

Abstract: The invention concerns a continuous reaction method by solid/gas catalysis in unconventional medium, using different substrates to obtain predetermined products, substrates and products forming compounds, which consists in controlling: the reaction in temperature to determine the saturation pressure of each pure compound taking part in determining the compound thermodynamic activity; the total pressure at a level lower than atmospheric pressure; the molar flow rates of the compounds and the vector gas, to adjust the gas mixture molar composition on the basis of the predetermined values of the thermodynamic activity of said compounds.